Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 20, 2022

SELL
$131.98 - $163.75 $548,376 - $680,381
-4,155 Closed
0 $0
Q4 2021

Jan 20, 2022

SELL
$107.43 - $135.93 $2,685 - $3,398
-25 Reduced 0.6%
4,155 $563,000
Q1 2021

Apr 13, 2021

SELL
$102.3 - $112.62 $428,227 - $471,427
-4,186 Reduced 50.04%
4,180 $452,000
Q4 2020

Jan 15, 2021

BUY
$80.49 - $108.67 $673,379 - $909,133
8,366 New
8,366 $896,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Prairiewood Capital, LLC Portfolio

Follow Prairiewood Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prairiewood Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prairiewood Capital, LLC with notifications on news.